Two days into a government shutdown over resulting from the Congressional showdown over funding Obamacare, funding is at the front of mind for many researchers who rely at least partially on grants from National Institutes of Health and other government sources. A survey of 608 translational researchers revealed that although insufficient funding is a significant barrier to the path to commercializing their work, there are other related challenges that are just as critical to their future.
How can translational researchers improve the rate of reproducible results? What other factors are undercutting funding? Where can they find collaboration opportunities?
{iframe}http://medcitynews.com/2013/10/can-translational-researchers-face-funding-reproduceible-result-challenges/{/iframe}